期刊文献+

血浆置换治疗移植肾复发性FSGS合并大量蛋白尿的远期观察 被引量:3

Long-term graft survival of recurrent FSGS in renal transplants with large number of proteinuria treated by plasma exchange
原文传递
导出
摘要 目的探讨血浆置换治疗移植肾复发性局灶性节段性肾小球硬化(FSGS)效果及其对远期预后的影响。方法6例患者首次肾移植后出现大量蛋白尿或/和血肌酐(Cr)升高、并经移植肾活检确诊为FSGS,在不改变免疫抑制方案的情况下,采用血浆置换治疗,观察血浆置换后1年移植肾的病理改变情况,测定血肌酐和24 h尿蛋白定量。结果6例患者中,2例在血浆置换后1年接近完全缓解,4例部分缓解。患者血浆置换后1年,移植肾的肾小球、肾间质、血管及免疫球蛋白病变的等级与血浆置换前相比,差异均无统计学意义。血浆置换后1年及5年的Cr水平与血浆置换前相比,差异均无统计学意义;24 h尿蛋白定量与血浆置换前相比,差异均有统计学意义(P<0.01,P<0.05)。结论血浆置换能快速、有效地缓解移植肾复发性FSGS的病变程度和进程,其效果取决于FSGS诊断的及时性,如果已发展到肾小球硬化的程度,血浆置换亦无法将其逆转。 Objective To investigate the efficacy of plasma exchange (PE) in the treatment of recurrent focal segmental glomerulosclerosis (FSGS) and its effect on the long-term graft survival of renal transplant. Methods From 1990 to 2000,6 patients with recurrent FSGS proven by graft biopsy were treated with PE respectively from 3 to 9 (5 % albumin, 1.5 plasma volumes) sessions,with signal angiotensin-converting enzyme (ACE) inhibitors (Benazepril hydrochloride,30 mg/day) and without changes of immunosuppressive agents. All patients were followed for up to 5 years, including serum creatitine (SCr), proteinuria (Pr), re-biopsy at 1 year after PE, and graft function at 5th year. Results Two patients had complete remission and 4 cases had partial remission. Pr had a significant reduction from 4. 60 ±2. 80 g/day to 1.96 ±2. 10 g/day one year post-pheresis (P〈0. 01), and decreased to 1.10 ±0. 80 g/day at 5th year (P〈0. 05). SCr was slightly increased from 164 ±38μmol/L up to 184 ±90μmol/L at first year (P〉0. 05) and up to 264 ±186μmol/L at 5th year (P〉0. 05). Four out of 6 patients kept their renal graft till 5 years with nearly normal function, one was in ESRD without hemodialysis and one had the graft removed. Graft re-biopsy showed that glomeruli lesion of FSGS at one year was not deteriorated (P〉0. 05). Conclusions PE is an effective form of treatment for recurrent FSGS by removing circulating factor, especially if initiated early. Failure to achieve remissions and maintain stable remission after the initial period of PE imply a poor outcome and glomeruli lesion been sclerosis. Therefore,PE should be performed as early as possible until completely remissions.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2006年第3期170-172,共3页 Chinese Journal of Organ Transplantation
关键词 肾移植 肾小球硬化症 病灶性 血浆置换 Kidney transplantation Glomerulosclerosis, focal Plasma exchange
  • 相关文献

参考文献10

  • 1Hariharan S,Peddi R,Savin V,et al.Recurrent and de novo renal disease after renal transplantation:a report from the renal allograft disease registry.Am J Kidney Dis,1998,31 :928.
  • 2Chabdan S.Glomerulonephritis recurrence in the renal graft.J Am Soc Nephrol,2001,12:394.
  • 3Lorraine CR,Kim S,Robert BC,et al.The Banff 97 working classification of renal allograft pathology.Kidney Int,1999,55:713-723.
  • 4Savin VJ,Artero M,Sharma R,et al.Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis.N Engl J Med,1966,334:878-883.
  • 5Godfrin Y,Dantal J,Perretto S,et al.Study of the in vitro effect of glomerular albumin permselectivity of serum before and after renal transplantation in focal segmental glomerulosclerosis.Transplantation,1997,4:1711.
  • 6Ceack JM,Terasaki PI.Chapter 1:the OPTN/UNOS renal transplant registry 2003.Clin Transpl,2003,19:1-13.
  • 7Andresdottir MB,Ajubi N,Croockewit S,et al.Recurrent focal glomerulosclerosis:natural course and treatment with plasma exchange.Nephrol Dial Transplant,1999,14:2650-2655.
  • 8Deegens JKJ,Andresdottir MB,Croockewit S,et al.Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplantation.Transpl Int,2004,17:151-157.
  • 9Ceack JM,Terasaki PI.Chapter 33:effect of primary diseases.Clin transpl,2003,19 :419-431.
  • 10Raafat R,Travis LB,Kalia A,et al.Role of transplant induction therapy on recurrence rate of focal segmental glomerulosclerosis.Pediatr Nephrol,2000,14:189-194.

同被引文献41

  • 1王太华,李清初,李秀春,钱家麒.足细胞与FSGS相关研究[J].国外医学(泌尿系统分册),2004,24(4):556-560. 被引量:3
  • 2杨林,彭爱民,夏进标,张祥文,钟文旗.贝那普利治疗局灶节段性肾小球硬化症的疗效[J].中国药师,2006,9(9):812-814. 被引量:2
  • 3Daskalakis N, Winn MP. Focal and segmental glomerulosclerosis: Varying biologic mechanisms underlie a final histopathologic end point. Semin Nephrol, 2006,26 : 89-94.
  • 4Deegens JKJ, Steenbergen EJ, Wetzels JFM. Review on diagnosis and treatment of focal segmental g[omerulosclerosis. Neth J Med, 2008,66:3- 12.
  • 5郑继光.局灶节段性肾小球硬化.见:谢佩法,陈严文,李正良,主编.实用肾脏病治疗学.吉林:吉林科学技术出版社,2005.129.
  • 6Cattran DC,Wang MM, Appel G, et al. Mycophenolate mofetilin the treatment of focal segmental glomerulosclerosis. Clin Nephrol, 2004,62:405-411.
  • 7Ito S, Maehida H, Inaba A, et al. Amelioration of steroids and cyclosporine resistant nephritic syndrome by pravastatin. Pediatr Nephrol, 2007,22 : 603 -606.
  • 8Loeffler K,Gowrishankar M, Yiu V. Tacrolimus therapy in pediatric paients with treatment resistant nephrotic syndrome. Pediatr Nephrol,2004,19 : 281- 287.
  • 9Tumlin JA, Miller D, Near M, et al. A prospective,open-label trial of sirolimus in the treatment of focal segmental glomeruloselerosis. Clin J Am Soc Nephrol,2006,1 : 109-116.
  • 10Goumenos DS, Tsagalis G, El Nahas AM, et al. Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: A five-year follow up study. Nephron Clin Praet, 2006,104: 75-82.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部